Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Total Current Assets
Fusion Antibodies PLC
Total Current Assets Peer Comparison
Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Total Current Assets
£1.8m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Total Current Assets
£447.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Total Current Assets
£42.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Total Current Assets
£30.9m
|
CAGR 3-Years
19%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Total Current Assets
£66.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Total Current Assets
£52m
|
CAGR 3-Years
20%
|
CAGR 5-Years
51%
|
CAGR 10-Years
45%
|
See Also
What is Fusion Antibodies PLC's Total Current Assets?
Total Current Assets
1.8m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Total Current Assets amounts to 1.8m GBP.
What is Fusion Antibodies PLC's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-13%
Over the last year, the Total Current Assets growth was -44%. The average annual Total Current Assets growth rates for Fusion Antibodies PLC have been -28% over the past three years , -13% over the past five years .